Acetyl Tetrapeptide-15
A topical cosmetic peptide marketed to reduce skin discomfort and hyperreactivity. Evidence is preliminary and largely supplier-associated.
- Human evidencen/a
- Animal evidencen/a
- Mechanisticn/a
- Safety knowledgen/a
- Editorial confidence3/5
Evidence Snapshot
- Overall
- 1/5Insufficient certainty
- Human
- 1/5Only review or summary sources indexed (not counted as primary human evidence)
- Animal
- 0/5None identified
- In-vitro
- 0/5None identified
- Safety
- 0/5None identified
Scientific identity
- Peptide family
- Sensitive-skin neuromodulating peptide
- Entity class
- Cosmetic peptide
- Alternative names
- SkinasensilAcetyl tetrapeptide 15
Developed for topical sensitive-skin cosmetics under the trade name Skinasensil, with proposed endorphin-like modulation of neuronal excitability and CGRP release.
Proposed Mechanisms
- not-yet-documentedpending-editorial-review
- Sensory neuropeptide modulation →limited
Reported / Studied Uses
- Skin ImprovementEvidence · weak
Human Evidence
Review literature cites early in vivo cosmetic testing, but robust independent randomized trials are lacking.
Animal Evidence
No robust animal efficacy evidence supporting routine cosmetic use was identified.
Safety & Unknowns
Regulatory Status
| Country | Status | Notes |
|---|
Community Observations
References
- No verified references linked yet. Editors will add primary sources.
Full Disclaimer
This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.
Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.
Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.